FDANonrulemakingFDA-2024-D-2682
Who commented on this docket
Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability
3 organizations filed 3 public comments on Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 679d ago.
Organizations
3
Comments
3
RIN
—
Comment window
closed 679d ago
Abstract
OPEN
Commenters (3)
- American Academy of Pediatrics (AAP)1 filing · confidence 97%
- Eli Lilly and Companyunverified attribution1 filing · confidence 70%
- The European Society of Pediatric Gastroenterologytrade assoc.1 filing · confidence 85%
Attribution is name-based and imperfect. regulations.gov data is public record.